HealthBanks Biotech USA is a leading provider of cord blood and immune cell banking services. Founded in 2001, they have established themselves as a reliable source for automated AXP II Cord Blood Processing, Automated PXP Immune Cell Processing, Automated BioArchive Cryostorage, FDA-approved collection materials and temperature-controlled cryopreservation vault. Their commitment to quality has been recognized by the California & New York Department of Health who have granted them licenses to operate.

In addition to their core services, HealthBanks also offers:

• Genetic testing services
• Cancer insurance packages
• Immunotherapy treatments such as CAR-T therapy

CAR-T therapy involves collecting T-cells from a patient's blood and modifying them with chimeric antigen receptors (CARs). This type of treatment was successfully used on Emily Whitehead after her diagnosis with acute lymphoblastic leukemia at age 5.

Finally, HealthBanks utilizes advanced cryogenic storage technology to ensure that cells remain viable for future use. They employ both manual MVE Dewars tanks which can store up to 5800 samples per tank as well as an automated BioArchive system with a robotic arm that deposits and retrieves individual cell samples submerged in liquid nitrogen while minimizing temperature fluctuations - resulting in up to 94% post-thaw cell viability rate. As the only private cell bank in the US using this technology, Healthbanks stands out among its competitors when it comes to preserving cells for future use.

Overall, HealthBanks Biotech USA is an excellent choice for those looking for reliable cord blood or immune cell banking services backed by quality assurance guarantees and cutting edge technologies like CAR-T therapy or cryogenic storage systems.